Coiante Scott M 4
4 · Aprea Therapeutics, Inc. · Filed Mar 26, 2020
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to Buy)
2020-03-24+55,000→ 55,000 totalExercise: $35.50Exp: 2030-03-24→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on March 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.